Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Oct;19(10):1006-1009.
doi: 10.1097/PCC.0000000000001712.

Understanding Disseminated Intravascular Coagulation and Hepatobiliary Dysfunction Multiple Organ Failure in Hyperferritinemic Critical Illness

Joseph A Carcillo  1 , Bita Shakoory, Dennis Simon, Kate Kernan
Affiliations
Editorial

Understanding Disseminated Intravascular Coagulation and Hepatobiliary Dysfunction Multiple Organ Failure in Hyperferritinemic Critical Illness

Joseph A Carcillo et al. Pediatr Crit Care Med. 2018 Oct.
No abstract available

PubMed Disclaimer

Figures

Figure
Figure
Understanding DIC and hepatobiliary multiple organ failure during sepsis
See this image and copyright information in PMC

Comment on

References

    1. Goldman J, Desai MS, McClain KL, et al. Hepatobiliary Dysfunction and Disseminated Intravascular Coagulation Increase Risk of Mortality in Pediatric Hemophagocytic Lymphohistiocytosis. Ped Crit Care Med. 2018 in press. - PMC - PubMed
    1. Shakoory B1, Carcillo JA, Chatham WW, et al. Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial. Crit Care Med. 2016 Feb;44(2):275–81. doi: 10.1097/CCM.0000000000001402. - DOI - PMC - PubMed
    1. Kyriazopoulou E, Leventogiannis K, Norrby-Teglund A, et al. Hellenic Sepsis Study Group. Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis. BMC Med. 2017 Sep 18;15(1):172. doi: 10.1186/s12916-017-0930-5. - DOI - PMC - PubMed
    1. Suster S, Hilsenbeck S, Rywlin AM. Reactive histiocytic hyperplasia with hemophagocytosis in hematopoietic organs: a reevaluation of the benign hemophagocytic proliferations. Hum Pathol. 1988 Jun;19(6):705–12. - PubMed
    1. Strauss R, Neureiter D, Westenburger B, et al. Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients--a postmortem clinicopathologic analysis. Crit Care Med. 2004 Jun;32(6):1316–21. - PubMed